These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3092395)

  • 1. Monoclonal antibodies towards the fast inhibitor of tissue plasminogen activator from human plasma and serum.
    Urdén G; Johansson U; Chmielewska J; Brandt J; Wiman B
    Thromb Haemost; 1986 Jun; 55(3):383-7. PubMed ID: 3092395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological relationship between plasminogen activator inhibitors from different sources.
    Urdén G; Chmielewska J; Carlsson T; Wiman B
    Thromb Haemost; 1987 Feb; 57(1):29-34. PubMed ID: 2438797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of fibrinolytic capacity by a combined assay system for tissue-type plasminogen activator antigen and function using monoclonal anti-tissue-type plasminogen activator antibodies.
    Wojta J; Turcu L; Wagner OF; Korninger C; Binder BR
    J Lab Clin Med; 1987 Jun; 109(6):665-71. PubMed ID: 3108431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen activator inhibitor-1 is the primary inhibitor of tissue-type plasminogen activator in pregnancy plasma.
    Jørgensen M; Philips M; Thorsen S; Selmer J; Zeuthen J
    Thromb Haemost; 1987 Oct; 58(3):872-8. PubMed ID: 3124286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production and characterization of monoclonal antibodies against tissue-type plasminogen activator.
    Ding H; Wang JY; Song HY
    Chin J Biotechnol; 1990; 6(3):223-7. PubMed ID: 2129498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A sensitive assay, specific for endothelial cell type plasminogen activator inhibitor in blood plasma.
    Sprengers ED
    Thromb Haemost; 1986 Feb; 55(1):74-7. PubMed ID: 3085268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The fast-acting inhibitor of tissue-type plasminogen activator in plasma is also the primary plasma inhibitor of urokinase.
    Kruithof EK; Tran-Thang C; Bachmann F
    Thromb Haemost; 1986 Feb; 55(1):65-9. PubMed ID: 3085266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological relationship between the fast-acting plasminogen activator inhibitors from plasma, blood platelets and endothelial cells demonstrated with a monoclonal antibody against an inhibitor from placenta.
    Philips M; Juul AG; Thorsen S; Selmer J; Zeuthen J
    Thromb Haemost; 1986 Apr; 55(2):213-7. PubMed ID: 2424117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daytime fluctuations in blood of tissue-type plasminogen activator (t-PA) and its fast-acting inhibitor (PAI-1).
    Kluft C; Jie AF; Rijken DC; Verheijen JH
    Thromb Haemost; 1988 Apr; 59(2):329-32. PubMed ID: 3133814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel fast inhibitor to tissue plasminogen activator in plasma, which may be of great pathophysiological significance.
    Wiman B; Chmielewska J
    Scand J Clin Lab Invest Suppl; 1985; 177():43-7. PubMed ID: 3934745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the release of a plasminogen activator inhibitor by human platelets.
    Kruithof EK; Tran-Thang C; Bachmann F
    Thromb Haemost; 1986 Apr; 55(2):201-5. PubMed ID: 2940723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A fibrin specific monoclonal antibody which interferes with the fibrinolytic effect of tissue plasminogen activator.
    Gargan PE; Ploplis VA; Scheu JD
    Thromb Haemost; 1988 Jun; 59(3):426-31. PubMed ID: 3142080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of two monoclonal antibodies against human tissue-type plasminogen activator.
    Schleef RR; Sinha M; Loskutoff DJ
    Thromb Haemost; 1985 Apr; 53(2):170-5. PubMed ID: 4040658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of monoclonal antibodies in the diagnosis of fibrinolysis].
    Wojta J; Korninger C; Kirchheimer J; Hattey E; Turcu L; Binder BR
    Wien Klin Wochenschr; 1985 Mar; 97(5):244-8. PubMed ID: 4039506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies to human 54,000 molecular weight plasminogen activator inhibitor from fibrosarcoma cells--inhibitor neutralization and one-step affinity purification.
    Nielsen LS; Andreasen PA; Grøndahl-Hansen J; Huang JY; Kristensen P; Danø K
    Thromb Haemost; 1986 Apr; 55(2):206-12. PubMed ID: 3520936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activator inhibitor 1 contains a cryptic high affinity receptor binding site that is exposed upon complex formation with tissue-type plasminogen activator.
    Horn IR; van den Berg BM; Moestrup SK; Pannekoek H; van Zonneveld AJ
    Thromb Haemost; 1998 Nov; 80(5):822-8. PubMed ID: 9843178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of monoclonal antibodies against human tissue plasminogen activator (tPA): quantitation of free tPA in human cell cultures by an ELISA.
    Kurokawa T; Toyoda Y; Iwasa S
    J Biochem; 1991 Feb; 109(2):217-22. PubMed ID: 1713912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal and hepatic handling of endogenous tissue-type plasminogen activator (t-PA) and its inhibitor in man.
    Brommer EJ; Derkx FH; Schalekamp MA; Dooijewaard G; vd Klaauw MM
    Thromb Haemost; 1988 Jun; 59(3):404-11. PubMed ID: 3142078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation, characterization and application of monoclonal antibodies against PAI-1.
    Ding H; Wu X; Zhou X; Zhu Y; Song H
    Chin J Biotechnol; 1994; 10(2):121-8. PubMed ID: 7803688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping of epitopes on human tissue-type plasminogen activator with recombinant deletion mutant proteins.
    van Zonneveld AJ; Veerman H; Brakenhoff JP; Aarden LA; Cajot JF; Pannekoek H
    Thromb Haemost; 1987 Feb; 57(1):82-6. PubMed ID: 2438798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.